Early clinical observations for a CD1d-Vδ2 bispecific T cell engager in patients with chronic lymphocytic leukemia and multiple myeloma

Conference

This ASH conference abstract reports early clinical and pharmacodynamic observations for LAVA-051, a CD1d-directed bispecific gamma-delta T cell engager studied in relapsed or refractory hematological malignancies.